Sapna Dhawan, MD
Clinical Neurophysiology · Tampa, FLNPI 1255656419
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 31.1% of the total. Reporting peaked in 2023 at $485 and has fallen 88.4% since, to $56 in 2025.
Across 33 payments — averaging $27.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$287
- Otsuka America Pharmaceutical, Inc.$160
- AbbVie$97
- Vanda Pharmaceuticals Inc.$66
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$57
- Teva Pharmaceuticals USA, Inc.$46
- plus $210 from 9 others
What the payments were for
- Food & beverage$923100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 7 | $287 |
| Otsuka America Pharmaceutical, Inc. | 3 | $160 |
| AbbVie | 4 | $97 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Lundbeck LLC | 2 | $38 |
| Alkermes, Inc. | 2 | $33 |
| Johnson & Johnson | 1 | $24 |
| Indivior Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Bioxcel Therapeutics, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Exact Sciences | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical neurophysiology providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 24 | $384 |
| Quetiapine Fumarate | 30 | $301 |
| Buspirone Hcl | 16 | $296 |
| Trazodone Hcl | 52 | $175 |
| Divalproex Sodium | 12 | $147 |
| Citalopram HbrCitalopram Hydrobromide | 17 | $141 |
| Amlodipine Besylate | 13 | $98 |
| Risperidone | 12 | $85 |
| Clonidine Hcl | 13 | $45 |
| Mirtazapine | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other clinical neurophysiology in Tampa
- Ernesto AlonsoLake City$211K
- Raam SambandamClermont$80K
- Noor YonoStuart$62K
- Rabih KashoutyStuart$34K
- Ellen EdgarSunny Isl Bch$9K
- Sheri BisbyWildwood$6K
- Isabella FerandoMiami$5K
- Joshua MendelsonFort Myers$3K
- Daniela RusoviciPort St John$3K
- Magdalena StepienOrlando$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.